Welcome!

News Feed Item

IMS Health Reports First-Quarter 2014 Results and Provides Full-Year Guidance

IMS Health Holdings, Inc. (“IMS Health”) (NYSE:IMS) a leading global provider of information and technology services to the healthcare and life sciences industries, today announced financial results for the quarter ended March 31, 2014.

First-Quarter 2014 Operating Results

Revenue for the first quarter increased 5.2 percent to $645 million, or 6.6 percent on a constant currency basis, compared with the first quarter of 2013. The company’s strong revenue performance was driven by an 11.9 percent increase in technology services, or 12.5 percent on a constant currency basis, year over year. Information offerings revenue grew 1.0 percent, or 2.8 percent on a constant currency basis, compared with the year-earlier period. Revenue at constant currency grew across all regions, with the emerging markets increasing 10.4 percent, or 14.7 percent at constant currency, and developed markets growing at 4.2 percent, or 5.0 percent at constant currency.

Adjusted EBITDA increased 7.2 percent to $217 million, or 9.5 percent on a constant currency basis, compared with the first quarter of 2013. This reflected both strong drop-through from revenue growth to Adjusted EBITDA and the impact of continued productivity improvements. Adjusted EBITDA as a percentage of revenue for the quarter improved 60 basis points to 33.7 percent. Operating income for the first quarter was $67 million, compared with $79 million for the prior-year period, with the change primarily due to increased non-cash stock-based compensation expense.

The first quarter 2014 net loss was $24 million, compared with net income of $12 million in last year’s first quarter. Adjusted net income was $70 million, down from $76 million in the prior year’s quarter, as improved operating performance was more than offset by a $10 million increase in interest expense due to higher debt levels and $10 million in higher cash taxes.

The diluted loss per share was $0.09 in the first quarter, compared with earnings per share of $0.04 in the first quarter of 2013. Diluted adjusted earnings per share was $0.24 in the first quarter, compared with $0.26 in the first quarter of 2013.

“In our final quarter before going public, we continued to deliver double-digit revenue growth in technology services and in emerging markets,” said Ari Bousbib, chairman and CEO, IMS Health. “We also continued to expand our margins by executing on our ongoing operational excellence program, even as we accelerated our investments in new capabilities.”

Financial Position

As of March 31, 2014, cash and cash equivalents and short-term investments were $544 million and debt was $5,027 million, resulting in net debt of $4,483 million. IMS Health’s gross leverage ratio was approximately 6.0 times the last twelve months Adjusted EBITDA at March 31, 2014. On a pro-forma basis post-IPO, after giving effect to the use of proceeds, this ratio would have been approximately 4.7 times the last twelve months Adjusted EBITDA at March 31, 2014.

Cash Flow

Net cash used in operating activities was $103 million in the 2014 first quarter. Capital spending and additions to deferred software were $33 million and $21 million, respectively.

Unlevered free cash flow for the first quarter was negative $11 million, compared with $57 million in the same quarter last year. The change principally reflected increased capital spending for the purchase of a new building in India to house the company’s Global Delivery Center and for new offerings software development, as well as higher growth in accounts receivable.

Recent Events

On April 4, 2014, IMS Health’s common stock began trading on the New York Stock Exchange, and on April 9, 2014, the company completed the initial public offering of its common stock at a price to the public of $20.00 per share. IMS Health issued and sold 52 million shares of common stock in the IPO. The selling shareholders offered and sold 22.75 million shares of common stock in the IPO, including 9.75 million shares that were offered and sold by the selling shareholders pursuant to the full exercise of the underwriters’ allotment to purchase additional shares. The company raised net proceeds of approximately $988 million from the IPO, after deducting underwriting discounts, commissions and related expenses.

Substantially all of the net proceeds from the sale of the 52 million primary shares were used to repay the company’s highest cost long-term debt. The company did not receive any of the proceeds from the sale of the 22.75 million shares by the selling shareholders.

Full-Year Guidance

For the full-year 2014, IMS Health expects revenue growth of 5 to 6 percent and Adjusted EBITDA growth of 7.5 to 9 percent. Adjusted net income is projected to grow 15 to 20 percent, while unlevered free cash flow is expected to be approximately 80 percent of Adjusted EBITDA, excluding the purchase of the company’s Global Delivery Center in India.

Constant Currency

IMS Health reports results in U.S. dollars, but does business on a global basis. Exchange rate fluctuations affect the U.S. dollar value of foreign currency revenue and expenses and may have a significant effect on results. The discussion of IMS Health’s financial results in this release includes comparisons with the prior year in constant currency terms, using consistent exchange rates. Management believes this information facilitates comparison of underlying results over time.

Non-GAAP Measures

This release presents certain “non-GAAP Measures” including Adjusted EBITDA, Adjusted Net Income and Unlevered Free Cash Flow because management believes these measures provide additional information regarding the company’s performance and its ability to service debt. In addition, management believes that these non-GAAP Measures are useful to assess the company’s operating performance trends because they exclude certain material non-cash items, unusual or non-recurring items that are not expected to continue in the future, and certain other items. These non-GAAP Measures are not presented in accordance with U.S. GAAP, and IMS Health’s computation of these non-GAAP Measures may vary from those used by other companies. These measures have limitations as an analytical tool, and should not be considered in isolation, or as a substitute or alternative to net income or loss, operating income or loss, cash flows from operating activities, total indebtedness or any other measures of operating performance, liquidity or indebtedness derived in accordance with GAAP. Reconciliations of these non-GAAP Measures to the most directly comparable GAAP measures and related notes are presented at the end of this release.

Conference Call and Webcast

IMS Health’s management team will host a conference call and webcast to discuss the company’s first-quarter 2014 results at 9:00 a.m. Eastern Time on May 1. Interested parties are invited to listen to the live event via webcast on IMS Health’s Investor Relations website at http://ir.imshealth.com. The discussion also will be available by dialing +1-800-404-5245 in the U.S. and Canada, or +1-303-223-2680 for international callers. A replay of the call and webcast will be available on the company’s Investor Relations site at http://ir.imshealth.com following the live call.

Forward-looking Statements

Reported numbers are preliminary and not final until the filing of our Form 10-Q with the Securities and Exchange Commission and, therefore, remain subject to adjustment. This press release includes “forward-looking statements” made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding future financial and operating results, especially those set forth under the heading “Full-Year Outlook.” The words “guidance,” “ongoing,” “believes,” “expects,” “may,” “will” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are not guarantees that the future results, plans, intentions or expectations expressed or implied will be achieved. Matters subject to forward-looking statements involve known and unknown risks and uncertainties, including regulatory, competitive and other factors, which may cause actual financial or operating results or the timing of events to be materially different than those expressed or implied by forward-looking statements. Important factors that could cause or contribute to such differences include, but are not limited to: imposition of restrictions on our use of data by data suppliers or their refusal to license data to us; failure to meet our productivity objectives; failure to successfully invest in growth opportunities; imposition of restrictions on our current and future activities under data protection and privacy laws; breaches or misuse of our or our outsourcing partners’ security or communication systems; hardware and software failures, delays in the operation of our computer and communications systems or the failure to implement system enhancements; consolidation in the industries in which our clients operate; our ability to protect our intellectual property rights and our susceptibility to claims by others that we are infringing on their intellectual property rights; the risks associated with operating on a global basis, including fluctuations in the value of foreign currencies relative to the U.S. dollar, and the ability to successfully hedge such risks; general economic conditions in the markets in which we operate, including financial market conditions; and the other factors set forth in the “Risk Factors” section of our registration statement on Form S-1 on file with the SEC and any subsequent SEC filings. Except as required by law, we specifically disclaim any obligation to update any forward-looking statements as a result of developments occurring after the date of this press release, even if estimates change, and you should not rely on those statements as representing our views as of any date subsequent to the date of this press release.

About IMS Health

IMS Health is a leading global information and technology services company providing clients in the healthcare industry with comprehensive solutions to measure and improve their performance. By applying sophisticated analytics and proprietary application suites hosted on the IMS One intelligent cloud, the company connects more than 10 petabytes of complex healthcare data on diseases, treatments, costs and outcomes to help its clients run their operations more efficiently. Drawing on information from 100,000 suppliers, and on insights from more than 45 billion healthcare transactions processed annually, IMS Health’s approximately 10,000 employees drive results for healthcare clients globally. Customers include pharmaceutical, consumer health and medical device manufacturers and distributors, providers, payers, government agencies, policymakers, researchers and the financial community.

IMSFIN

   

Table 1

IMS Health Holdings, Inc.

Income Statement

(unaudited, in millions except per share)

 
Three Months Ended

March 31,

  2014         2013  
   
Revenue $ 645       $ 613  
Information 381 378
Technology services   264         235  
Operating costs of information, exclusive of depreciation and amortization 164 160
Direct and incremental costs of technology services, exclusive of depreciation and amortization 136 123
Selling and administrative expenses, exclusive of depreciation and amortization 171 145
Depreciation and amortization 107 105
Severance, impairment and other charges   -         1  
Operating Income   67         79  
Interest income 2 1
Interest expense (89 ) (79 )
Other (loss) income, net   (17 )       16  
Non-Operating Loss, Net   (104 )       (62 )
(Loss) Income before income taxes (37 ) 17
Benefit from (provision for) income taxes   13         (5 )
Net (Loss) Income $ (24 ) $ 12
(Loss) Earnings per Share Attributable to Common Shareholders:
Basic $ (0.09 ) $ 0.04
Diluted $ (0.09 ) $ 0.04
Weighted-Average Common Shares Outstanding:
Basic 279.9 280.0
Diluted 279.9 288.7
 

   

Table 2

IMS Health Holdings, Inc.

Net (Loss) Income to Adjusted EBITDA Reconciliation

(unaudited, in millions)

 
Three Months Ended

March 31,

  2014         2013  
   
Net (Loss) Income $ (24 ) $ 12
(Benefit from) provision for income taxes (13 ) 5
Other loss (income), net 17 (16 )
Interest expense 89 79
Interest income (2 ) (1 )
Depreciation and amortization 107 105
Deferred revenue purchase accounting adjustments 2 1
Non-cash stock-based compensation charges 31 11
Restructuring and related charges(1) 2 3
Acquisition-related charges 6 2
Sponsor monitoring fees   2         2  
Adjusted EBITDA $ 217 $ 203
 

(1)

 

Restructuring and related charges includes severance and impairment charges and the cost of employee and third-party charges related to dual running costs for knowledge transfer activities.

 

   

Table 3

IMS Health Holdings, Inc.

Net (Loss) Income to Adjusted Net Income Reconciliation

(unaudited, in millions except per share)

 
Three Months Ended

March 31,

  2014         2013  
   
Net (Loss) Income $ (24 ) $ 12
(Benefit from) provision for income taxes (13 ) 5
Amortization associated with purchase accounting 76 75
Deferred revenue purchasing accounting adjustment 2 1
Non-cash stock-based compensation charges 31 11
Restructuring and related charges(1) 2 3
Acquisition-related charges 6 2
Sponsor monitoring fees 2 2
Other loss (income), net   17         (16 )
Adjusted Pre Tax Income $ 99 $ 95
Less cash tax (payments)/refunds   (29 )       (19 )
Adjusted Net Income $ 70       $ 76  
 
Earnings per Share Attributable to Common Shareholders:
Basic $ 0.25 $ 0.27
Diluted $ 0.24 $ 0.26
Weighted-Average Common Shares Outstanding:
Basic 279.9 280.0
Diluted 288.1 288.7
 

(1)

 

Restructuring and related charges includes severance and impairment charges and the cost of employee and third-party charges related to dual running costs for knowledge transfer activities.

 

   

Table 4

IMS Health Holdings, Inc.

Reconciliation of Net Cash Used in Operating Activities

to Unlevered Free Cash Flow

(unaudited, in millions)

 
Three Months Ended

March 31,

  2014         2013  
   
Net Cash Used in Operating Activities $ (103 ) $ (16 )
Capital expenditures (33 ) (7 )
Additions to computer software   (21 )       (14 )
Free Cash Flow $ (157 ) $ (37 )
Cash interest payments 102 67
Cash tax payments 29 19
Acquisition related charges 6 2
Sponsor monitoring fees 2 2
Severance, transaction & other payments 5 5
FX hedge payments   1         (1 )
Unlevered Free Cash Flow $ (11 ) $ 57
 
   

Table 5

IMS Health Holdings, Inc.

Calculation of Gross Leverage Ratio

as of March 31, 2014

(unaudited, in millions)

 
Gross Debt as of March 31, 2014 5,027
 
Adjusted EBITDA for the year ended December 31, 2013(1) 829
Less: Adjusted EBITDA for the three months ended March 31, 2013 (203)
Add: Adjusted EBITDA for the three months ended March 31, 2014 217
 
Adjusted EBITDA for the twelve months ended March 31, 2014 843
 
Gross Leverage Ratio (Gross Debt/Adjusted EBITDA) 6.0x
 

(1)

 

A reconciliation of Net Income (Loss) to Adjusted EBITDA for the year ended December 31, 2013 is provided in the prospectus summary section of our registration statement on Form S-1 on file with the SEC.

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that SoftLayer, an IBM Company, has been named “Gold Sponsor” of SYS-CON's 18th Cloud Expo, which will take place on June 7-9, 2016, at the Javits Center in New York, New York. SoftLayer, an IBM Company, provides cloud infrastructure as a service from a growing number of data centers and network points of presence around the world. SoftLayer’s customers range from Web startups to global enterprises.
Cloud promises the agility required by today’s digital businesses. As organizations adopt cloud based infrastructures and services, their IT resources become increasingly dynamic and hybrid in nature. Managing these require modern IT operations and tools. In his session at 20th Cloud Expo, Raj Sundaram, Senior Principal Product Manager at CA Technologies, will discuss how to modernize your IT operations in order to proactively manage your hybrid cloud and IT environments. He will be sharing bes...
In his opening keynote at 20th Cloud Expo, Michael Maximilien, Research Scientist, Architect, and Engineer at IBM, will motivate why realizing the full potential of the cloud and social data requires artificial intelligence. By mixing Cloud Foundry and the rich set of Watson services, IBM's Bluemix is the best cloud operating system for enterprises today, providing rapid development and deployment of applications that can take advantage of the rich catalog of Watson services to help drive insigh...
Cloud applications are seeing a deluge of requests to support the exploding advanced analytics market. “Open analytics” is the emerging strategy to deliver that data through an open data access layer, in the cloud, to be directly consumed by external analytics tools and popular programming languages. An increasing number of data engineers and data scientists use a variety of platforms and advanced analytics languages such as SAS, R, Python and Java, as well as frameworks such as Hadoop and Spark...
IBM helps FinTechs and financial services companies build and monetize cognitive-enabled financial services apps quickly and at scale. Hosted on IBM Bluemix, IBM’s platform builds in customer insights, regulatory compliance analytics and security to help reduce development time and testing. In his session at 20th Cloud Expo, Tom Eck, Industry Platforms CTO at IBM Cloud, will discuss how these tools simplify the time-consuming tasks of selection, mapping and data integration, allowing developers ...
Existing Big Data solutions are mainly focused on the discovery and analysis of data. The solutions are scalable and highly available but tedious when swapping in and swapping out occurs in disarray and thrashing takes place. The resolution for thrashing through machine learning algorithms and support nomenclature is through simple techniques. Organizations that have been collecting large customer data are increasingly seeing the need to use the data for swapping in and out and thrashing occurs ...
Regardless of what business you’re in, it’s increasingly a software-driven business. Consumers’ rising expectations for connected digital and physical experiences are driving what some are calling the "Customer Experience Challenge.” In his session at @DevOpsSummit at 20th Cloud Expo, Marco Morales, Director of Global Solutions at CollabNet, will discuss how organizations are increasingly adopting a discipline of Value Stream Mapping to ensure that the software they are producing is poised to o...
SYS-CON Events announced today that delaPlex will exhibit at SYS-CON's @CloudExpo, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. delaPlex pioneered Software Development as a Service (SDaaS), which provides scalable resources to build, test, and deploy software. It’s a fast and more reliable way to develop a new product or expand your in-house team.
For financial firms, the cloud is going to increasingly become a crucial part of dealing with customers over the next five years and beyond, particularly with the growing use and acceptance of virtual currencies. There are new data storage paradigms on the horizon that will deliver secure solutions for storing and moving sensitive financial data around the world without touching terrestrial networks. In his session at 20th Cloud Expo, Cliff Beek, President of Cloud Constellation Corporation, w...
With major technology companies and startups seriously embracing Cloud strategies, now is the perfect time to attend @CloudExpo | @ThingsExpo, June 6-8, 2017, at the Javits Center in New York City, NY and October 31 - November 2, 2017, Santa Clara Convention Center, CA. Learn what is going on, contribute to the discussions, and ensure that your enterprise is on the right path to Digital Transformation.
SYS-CON Events announced today that EARP Integration will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. EARP Integration is a passionate software house. Since its inception in 2009 the company successfully delivers smart solutions for cities and factories that start their digital transformation. EARP provides bespoke solutions like, for example, advanced enterprise portals, business intelligence systems an...
SYS-CON Events announced today that Outscale, a global pure play Infrastructure as a Service provider and strategic partner of Dassault Systèmes, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Founded in 2010, Outscale simplifies infrastructure complexities and boosts the business agility of its customers. Outscale delivers a secure, reliable and industrial strength solution for its customers, which in...
SYS-CON Events announced today that Progress, a global leader in application development, has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Enterprises today are rapidly adopting the cloud, while continuing to retain business-critical/sensitive data inside the firewall. This is creating two separate data silos – one inside the firewall and the other outside the firewall. Cloud ISVs oft...
Interested in leveling up on your Cloud Foundry skills? Join IBM for Cloud Foundry Days on June 7 at Cloud Expo New York at the Javits Center in New York City. Cloud Foundry Days is a free half day educational conference and networking event. Come find out why Cloud Foundry is the industry's fastest-growing and most adopted cloud application platform.
In order to meet the rapidly changing demands of today’s customers, companies are continually forced to redefine their business strategies in order to meet these needs, stay relevant and continue to see profitable growth. IoT deployment and development is integral in this transformation, and today businesses are increasingly seeing the value of investing their resources into IoT deployments. These technologies are able increase ROI through projects such as connecting supply chains or enabling sm...